Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Hennessy

Showing results (51-60 of 266) with videos related to

Pageof 27
Sort By:
Pharmacoepidemiology and Drug Safety|March 8, 2003
Enhancement of medication recall using medication pictures and lists in telephone interviewsStephen E Kimmel, James D Lewis, Jane Jaskowiak, et al.
BMJ Open|October 9, 2017
Financial incentives to discontinue long-term benzodiazepine use: a discrete choice experiment investigating patient preferences and willingness to participateJoachim Marti, Marcus Bachhuber, Jordyn Feingold, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 4, 2012
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension on clinical end points: a cohort studyJason Roy, Nirav R Shah, G Craig Wood, et al.
Pharmacoepidemiology and Drug Safety|June 7, 2022
Very high PD-L1 expression as a prognostic indicator of overall survival among patients with advanced non-small cell lung cancer receiving anti-PD-(L)1 monotherapies in routine practiceMohsin Shah, Rebecca A Hubbard, Ronac Mamtani, et al.
Epidemiology (Cambridge, Mass.)|October 2, 2018
Re. Trends in Control of Unobserved ConfoundingAshkan Ertefaie, Dylan S Small, Charles E Leonard, et al.
Clinical Pharmacology and Therapeutics|December 13, 2024
Risk of Hypoglycemia Associated With Concomitant Use of Insulin Secretagogues and ACE Inhibitors in Adults With Type 2 Diabetes: A Systematic ReviewPatricia Y Chu, Emma K Edmondson, James H Flory, et al.
Drug Safety|August 7, 2022
Patient-Reported Reasons for Switching or Discontinuing Statin Therapy: A Mixed Methods Study Using Social MediaSu Golder, Davy Weissenbacher, Karen O'Connor, et al.
Pharmacoepidemiology and Drug Safety|January 27, 2012
Factors associated with the initiation of proton pump inhibitors in corticosteroid usersJeffrey C Munson, Peter M Wahl, Gregory Daniel, et al.
American Journal of Epidemiology|August 1, 2024
Grace periods and exposure misclassification in self-controlled case-series studies of drug-drug interactionsHanxi Zhang, Warren B Bilker, Charles E Leonard, et al.
Drug Safety|January 15, 2021
Correction to: A Comparative View of Reported Adverse Effects of Statins in Social Media, Regulatory Data, Drug Information Databases and Systematic ReviewsSu Golder, Karen Smith, Karen O'Connor, et al.
Pageof 27

Showing results (51-60 of 266) with videos related to

Sort By:
Pageof 27
Pharmacoepidemiology and Drug Safety|March 8, 2003
Enhancement of medication recall using medication pictures and lists in telephone interviewsStephen E Kimmel, James D Lewis, Jane Jaskowiak, et al.
BMJ Open|October 9, 2017
Financial incentives to discontinue long-term benzodiazepine use: a discrete choice experiment investigating patient preferences and willingness to participateJoachim Marti, Marcus Bachhuber, Jordyn Feingold, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 4, 2012
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension on clinical end points: a cohort studyJason Roy, Nirav R Shah, G Craig Wood, et al.
Pharmacoepidemiology and Drug Safety|June 7, 2022
Very high PD-L1 expression as a prognostic indicator of overall survival among patients with advanced non-small cell lung cancer receiving anti-PD-(L)1 monotherapies in routine practiceMohsin Shah, Rebecca A Hubbard, Ronac Mamtani, et al.
Epidemiology (Cambridge, Mass.)|October 2, 2018
Re. Trends in Control of Unobserved ConfoundingAshkan Ertefaie, Dylan S Small, Charles E Leonard, et al.
Clinical Pharmacology and Therapeutics|December 13, 2024
Risk of Hypoglycemia Associated With Concomitant Use of Insulin Secretagogues and ACE Inhibitors in Adults With Type 2 Diabetes: A Systematic ReviewPatricia Y Chu, Emma K Edmondson, James H Flory, et al.
Drug Safety|August 7, 2022
Patient-Reported Reasons for Switching or Discontinuing Statin Therapy: A Mixed Methods Study Using Social MediaSu Golder, Davy Weissenbacher, Karen O'Connor, et al.
Pharmacoepidemiology and Drug Safety|January 27, 2012
Factors associated with the initiation of proton pump inhibitors in corticosteroid usersJeffrey C Munson, Peter M Wahl, Gregory Daniel, et al.
American Journal of Epidemiology|August 1, 2024
Grace periods and exposure misclassification in self-controlled case-series studies of drug-drug interactionsHanxi Zhang, Warren B Bilker, Charles E Leonard, et al.
Drug Safety|January 15, 2021
Correction to: A Comparative View of Reported Adverse Effects of Statins in Social Media, Regulatory Data, Drug Information Databases and Systematic ReviewsSu Golder, Karen Smith, Karen O'Connor, et al.
Pageof 27